The Supreme Court heard arguments this week on whether products involving human genes can be patented, a landmark case that could impact New Jersey's biotech industry.
Covance Inc., the Princeton-based provider of drug development services, today announced the completion of its Singapore lab expansion, part of its strategy to meet current and future growth in the Asia Pacific region.
Lourdes Specialty Hospital of Southern New Jersey, which treats patients who require extended hospital stays before returning home, announced Monday it is more than doubling its footprint, to two floors of Lourdes Medical Center, in Willingboro.
LifeCell Corp., of Bridgewater, on Friday announced its board of directors appointed Joe Woody, president and CEO of LifeCell sister company Kinetic Concepts Inc., as interim CEO of LifeCell.
Toms River-based DermOne Dermatology Centers announced Thursday its expansion into the state of Virginia through the acquisition of the private dermatology practice of Dr. Gerald C. Burnett.
As part of health care reform, hospitals will be increasingly reimbursed — and penalized — based on data submitted to the Centers for Medicare and Medicaid Services for things like rehospitalization, patient satisfaction and proper discharge protocols and follow-ups. These quality measurements, called value-based purchasing, are being...
Publisher Intellisphere LLC, in Plainsboro, announced Thursday the industry journal Pharmacy Times and its sister publication, Specialty Pharmacy Times, have added nine more companies to its strategic alliance partnership programs.
Hackensack University Medical Center announced Wednesday it will partner with recycling pioneer TerraCycle, of Princeton, to convert difficult-to-recycle items such as keyboards and mice, diaper packaging, chip bags, and writing utensils into eco-friendly consumer products and industrial applications.
Parsippany-based One Call Care Management, a provider of services that lead to more efficient resolutions of claims, on Wednesday announced President Joe Delaney will now also serve as CEO of the company.
Rutherford-based Cancer Genetics Inc., a diagnostics company focused on developing genomic-based oncology tests and services, today announced it has closed its initial public offering of 690,000 shares of common stock at a price to the public of $10 per share.
Catalent Pharma Solutions, in the Somerset section of Franklin, on Wednesday announced it has acquired an exclusive license to market Redwood Bioscience’s proprietary SmarTag technology for the development of advanced antibody-drug conjugates.
Cranbury-based biotechnology company VaxInnate Corp. has received a $2.2 million grant from the federal government to develop a vaccine to prevent dengue, a mosquito-borne viral disease that kills about 25,000 people annually worldwide.